A. Bernareggi
Impact in
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacogenetics and Drug Metabolism
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Drug Transport and Resistance Mechanisms
- Metal complexes synthesis and properties
Papers in
- Pharmacology 20
- Antibiotics Pharmacokinetics and Efficacy 14
-
- Anesthesia and Sedative Agents 6
- Co-authors
- Malcolm RowlandAlessandro AssandriGabriella CamboniJack W. SingerScott A. ShafferScott StromattBrian BakerCecilia Allievi
- Journals
- Journal of Clinical Oncology (8 papers)Antimicrobial Agents and Chemotherapy (6 papers)Annals of Oncology (5 papers)Clinical Cancer Research (3 papers)Anti-Cancer Drugs (2 papers)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
A. Bernareggi
59 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 107
- Pharmacology 288
- Oncology 432
- Pharmacology 131
- Biomaterials 143
- Clinical Biochemistry 71
Countries citing papers authored by A. Bernareggi
This map shows the geographic impact of A. Bernareggi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Bernareggi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Bernareggi more than expected).
Fields of papers citing papers by A. Bernareggi
This network shows the impact of papers produced by A. Bernareggi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Bernareggi. The network helps show where A. Bernareggi may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Bernareggi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 5 | |
| 2 | 2018 | 1 | |
| 3 | 2017 | 2 | |
| 4 | 2017 | 0 | |
| 5 | 2007 | 23 | |
| 6 | 2004 | 3 | |
| 7 | 2001 | 44 | |
| 8 | 2000 | 33 | |
| 9 | 2000 | 59 | |
| 10 | A phase I study of a novel, trinuclear, platinum analogue, BBR3464, in patients with advanced solid tumors | 1999 | 7 |
| 11 | 1996 | 20 | |
| 12 | 1995 | 2 | |
| 13 | 1994 | 5 | |
| 14 | 1994 | 6 | |
| 15 | 1993 | 35 | |
| 16 | 1992 | 25 | |
| 17 | 1992 | 41 | |
| 18 | 1990 | 21 | |
| 19 | 1987 | 58 | |
| 20 | 1987 | 10 |
About A. Bernareggi
A. Bernareggi is a scholar working on Pharmacology, Anesthesiology and Pain Medicine, Pharmacology, Oncology and Analytical Chemistry, having authored 63 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (14 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers), Nausea and vomiting management (8 papers), Cancer therapeutics and mechanisms (7 papers), Analytical Methods in Pharmaceuticals (6 papers), Anesthesia and Sedative Agents (6 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Analytical Chemistry and Chromatography (5 papers). The work is most often cited by research in Pharmacology (288 citations), Oncology (432 citations), Pharmacology (131 citations), Biomaterials (143 citations) and Clinical Biochemistry (71 citations). A. Bernareggi has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Malcolm Rowland, Alessandro Assandri, Gabriella Camboni, Jack W. Singer, Scott A. Shaffer, Scott Stromatt, Brian Baker, Cecilia Allievi, Gino Beggiolin and P. Di Blasi. Their work appears in journals such as Journal of Clinical Oncology, Antimicrobial Agents and Chemotherapy, Annals of Oncology, Clinical Cancer Research and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.